Myocardial protection by anesthetic agents against ischemia-reperfusion injury: An update for anesthesiologists;La protection myocardique contre les lésions d'ischémie-reperfusion par des anesthésiques: Une mise à jour pour les anesthésiologistes

Canadian Journal of Anesthesia

Volumn 49, Issue 8, 2002, Pages 777-791

  Kato, Rie ^a   Foëx, Pierre ^b  

^a CHIBA UNIVERSITY   (Japan)

^b UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALFENTANIL; ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; ANESTHETIC AGENT; BARBITURIC ACID DERIVATIVE; BENZODIAZEPINE DERIVATIVE; BUPRENORPHINE; DESFLURANE; ENFLURANE; FENTANYL; GLIBENCLAMIDE; HALOTHANE; ISOFLURANE; KETAMINE; MORPHINE; NALOXONE; OPIATE; OPIATE AGONIST; PENTAZOCINE; PENTOBARBITAL; PROPOFOL; PROTEIN KINASE INHIBITOR; REMIFENTANIL; SEVOFLURANE; SUFENTANIL; THIAMYLAL; THIOPENTAL; XYLAZINE;

ANESTHESIST; ANTIOXIDANT ACTIVITY; ARTICLE; CALCIUM TRANSPORT; CYTOSOL; DATA BASE; DRUG EFFECT; DRUG EFFICACY; DRUG MECHANISM; DRUG POTENCY; HEART INFARCTION PREVENTION; HEART MUSCLE ISCHEMIA; HEART PROTECTION; HUMAN; MEDLINE; NEUTROPHIL; NONHUMAN; PRIORITY JOURNAL; REPERFUSION INJURY; THROMBOCYTE; VASCULAR ENDOTHELIUM;

EID: 0036817178     PISSN: 0832610X     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF03017409     Document Type: Article

References (134)

1. Freedman BM, Hamm DP, Everson CT, Wechsler AS, Christian CM II. Enflurane enhances postischemic functional recovery in the isolated rat heart. Anesthesiology 1985; 62: 29-33.
2. Schultz JEJ, Rose E, Yao Z, Gross GJ. Evidence for involvement of opioid receptors in ischemic preconditioning in rat hearts. Am J Physiol 1995; 268: H2157-61.
3. Schultz JEJ, Hsu AK, Gross GJ. Morphine mimics the cardioprotective effect of ischemic preconditioning via a glibenclamide-sensitive mechanism in the rat heart. Circ Res 1996; 78: 1100-4.
4. Murphy PG, Myers DS, Davies MJ, Webster NR, Jones JG. The antioxidant potential of propofol (2,6- diisopropylphenol). Br J Anaesth 1992; 68: 613-8.
5. Kahraman S, Demiryurek AT Propofol is a peroxynitrite scavenger. Anesth Analg 1997; 84: 1127-9.
6. Ko SH, Yu CW, Lee SK, et al. Propofol attenuates ischemia-reperfusion injury in the isolated rat heart. Anesth Analg 1997; 85: 719-24.
7. Kokita N, Hara A, Abiko T, Arakawa J, Hashizume H, Namiki A. Propofol improves functional and metabolic recovery in ischemic reperfused isolated rat hearts. Anesth Analg 1998; 86: 252-8.
8. ATP channels and interaction with the sodium-hydrogen exchange inhibitor HOE 642 (cariporide). Anesthesiology 1999; 91: 1349-60.
9. Javadov SA, Lim KHH, Kerr PM, Suleiman MS, Angelini GD, Halestrap AP. Protection of hearts from reperfusion injury by propofol is associated with inhibition of the mitochondrial permeability transition. Cardiovasc Res 2000; 45: 360-9.
10. Yoo KY, Yang SY, Lee J, et al. Intracoronary propofol attenuates myocardial but not coronary endothelial dysfunction after brief ischaemia and reperfusion in dogs. Br J Anaesth 1999; 82: 90-6.
11. Ross S, Foex P. Protective effects of anaesthetics in reversible and irreversible ischaemia-reperfusion injury. Br J Anaesth 1999; 82: 622-32.
12. Dickersin K, Scherer R, Lefebvre C. Identifying relevant studies for systematic reviews. In: Chalmers I, Altman DG (Eds.). Systematic Reviews. London: BMJ Publishing Group, 1995: 17-36.
13. Opie LH. Cell death: myocardial infarction. In: Opie LH (Ed.). The Heart. Physiology, from Cell to Circulation, 3rd ed. Philadelphia: Lippincott-Raven Publishers, 1998: 543-61.
14. Opie LH. Myocardial reperfusion: new ischemic syndromes. In: Opie LH (Ed.). The Heart. Physiology, from Cell to Circulation, 3rd ed. Philadelphia: Lippincott- Ravens Publishers, 1998: 563-88.
15. Opie LH. Oxygen lack: ischemia and angina. In: Opie LH (Ed.). The Heart. Physiology, from Cell to Circulation, 3rd ed. Philadelphia: Lippincott-Ravens Publishers, 1998: 515-41.
16. Maxwell SRJ, Lip GYH. Reperfusion injury: a review of the pathophysiology, clinical manifestations and therapeutic options. Int J Cardiol 1997; 58: 95-117.
17. Jordan JE, Zhao ZQ, Vinten-Johansen J. The role of neutrophils in myocardial ischemia-reperfusion injury. Cardiovasc Res 1999; 43: 860-78.
18. Bolli R, Marban E. Molecular and cellular mechanisms of myocardial stunning. Physiol Rev 1999; 79: 609-34.
19. Braunwald E, Kloner RA. The stunned myocardium: prolonged, postischemic ventricular dysfunction. Circulation 1982; 66: 1146-9.
20. Okubo S, Xi L, Bernardo NL, Yoshida K, Kukreja RC. Myocardial preconditioning: basic concepts and potential mechanisms. Mol Cell Biochem 1999; 196: 3-12.
21. Nakano A, Cohen MV, Downey JM. Ischemic preconditioning. From basic mechanisms to clinical applications. Pharmacol Ther 2000; 86: 263-75.
22. Rubino A, Yellon DM. Ischaemic preconditioning of the vasculature: an overlooked phenomenon for protecting the heart? Trends Pharmacol Sci 2000; 21: 225-30.
23. Murry CE, Jennings RB, Reimer KA. Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium. Circulation 1986; 74: 1124-36.
24. Tomai F, Crea F, Chiariello L, Gioffre PA. Ischemic preconditioning in humans. Models, mediators, and clinical relevance. Circulation 1999; 100: 559-63.
25. Lu EX, Chen SX, Hu TH, Xui LM, Yuan MD. Preconditioning enhances myocardial protection in patients undergoing open heart surgery. Thorac Cardiovasc Surg 1998; 46: 28-32.
26. Li G, Chen S, Lu E, Li Y Ischemic preconditioning improves preservation with cold blood cardioplegia in valve replacement patients. Eur J Cardiothorac Surg 1999; 15: 653-7.
27. Szmagala P, Morawski W, Krejca M, Gburek T, Bochenek A. Evaluation of perioperative myocardial tissue damage in ischemically preconditioned human heart during aorto coronary bypass surgery. J Cardiovasc Surg (Torino) 1998; 39: 791-5.
28. Warltier DC Al Wathiqui MH Kampine JP, Schmeling WT. Recovery of contractile function of stunned myocardium in chronically instrumented dogs is enhanced by halothane or isoflurane. Anesthesiology 1988; 69: 552-65.
29. Cason BA, Gamperl AK, Slocum RE, Hickey RF Anesthetic- induced preconditioning. Previous administration of isoflurane decreases myocardial infarct size in rabbits. Anesthesiology 1997; 87: 1182-90.
30. Cope DK, Impastato WK, Cohen MV, Downey JM. Volatile anesthetics protect the ischemic rabbit myocardium from infarction. Anesthesiology 1997; 86: 699-709.
31. ATP channels. Reduction of myocardial infarct size with an acute memory phase. Anesthesiology 1997; 87: 361-70.
32. Kowalski C, Zahler S, Becker BE et al. Halothane, isoflurane, and sevoflurane reduce postischemic adhesion of neutrophils in the coronary system. Anesthesiology 1997; 86: 188-95.
33. Lochner A, Genade S, Tromp E, Theron S, Trollip G. Postcardioplegic myocardial recovery: effects of halothane, nifedipine, HOE 694, and quinacrine. Cardiovasc Drugs Ther 1998; 12: 267-77.
34. Preckel B, Schlack W, Comfere T, Obal D, Barthel H, Thamer V Effects of enflurane, isoflurane, sevoflurane and desflurane on reperfusion injury after regional myocardial ischaemia in the rabbit heart in vivo. Br J Anaesth 1998; 81: 905-12.
35. Preckel B, Schlack W, Thamer V Enflurane and isoflurane, but not halothane, protect against myocardial reperfusion injury after cardioplegic arrest with HTK solution in the isolated rat heart. Anesth Analg 1998; 87: 1221-7.
36. Schlack W, Preckel B, Stunneck D, Thamer V Effects of halothane, enflurane, isoflurane, sevoflurane and desflurane on myocardial reperfusion injury in the isolated rat heart. Br J Anaesth 1998; 81: 913-9.
37. Heindl B, Reichle FM, Zahler S, Conzen PF, Becker BF Sevoflurane and isoflurane protect the reperfused guinea pig heart by reducing postischemic adhesion of polymorphonuclear neutrophils. Anesthesiology 1999; 91: 521-30.
38. Ismaeil MS, Tkachenko I, Gamperl AK, Hickey RE, Cason BA. Mechanisms of isoflurane-induced myocardial preconditioning in rabbits. Anesthesiology 1999; 90: 812-21.
39. Piriou V, Chiari P, Knezynski S, et al. Prevention of isoflurane-induced preconditioning by 5- hydroxydecanoate and gadolinium. Possible involvement of mitochondrial adenosine triphosphate-sensitive potassium and stretch-activated channels. Anesthesiology 2000; 93: 756-64.
40. Shimizu J, Sakamoto A, Ogawa, R. Activation of the adenosine triphosphate sensitive mitochondrial potassium channel is involved in the cardioprotective effect of isoflurane. J Nippon Med Sch 2001; 68: 238-45.
41. Toller WG, Kersten JR, Gross ER, Pagel PS, Warltier DC. Isoflurane preconditions myocardium against infarction via activation of inhibitory guanine nucleotide binding proteins. Anesthesiology 2000; 92: 1400-7.
42. Toller WG, Montgomery MW, Pagel PS, Hettrick DA, Warltier DC, Kersten JR. Isoflurane-enhanced recovery of canine stunned myocardium. Role for protein kinase C? Anesthesiology 1999; 91: 713-22.
43. Coetzee JF, le Roux PJ, Genade S, Lochner A. Reduction of postischemic contractile dysfunction of the isolated rat heart by sevoflurane: comparison with halothane. Anesth Analg 2000; 90: 1089-97.
44. 1 receptors and adenosine triphosphate-sensitive potassium channels. Anesthesiology 2000; 92: 1692-701.
45. Heindl B, Becker BF Zahler S, Conzen PF. Volatile anaesthetics reduce adhesion of blood platelets under low-flow conditions in the coronary system of isolated guinea pig hearts. Acta Anaesthesiol Scand 1998; 42: 995-1003.
46. Novalija E, Stowe DF. Prior preconditioning by ischemia or sevoflurane improves cardiac work per oxygen use in isolated guinea pig hearts after global ischemia. Adv Exp Med Biol 1998; 454: 533-42.
47. Heindl B, Conzen PF, Becker BE. The volatile anesthetic sevoflurane mitigates cardiodepressive effects of platelets in reperfused hearts. Basic Res Cardiol 1999; 94: 102-11.
48. Novalija E, Fujita S, Kampine JP, Stowe DF. Sevoflurane mimics ischemic preconditioning effects on coronary flow and nitric oxide release in isolated hearts. Anesthesiology 1999; 91: 701-12.
49. Preckel B, Thamer V, Schlack W. Beneficial effects of sevoflurane and desflurane against myocardial reperfusion injury after cardioplegic arrest. Can J Anesth 1999; 46: 1076-81.
50. Toller WG, Kersten JR, Pagel PS, Hettrick DA, Warltier DC. Sevoflurane reduces myocardial infarct size and decreases the time threshold for ischemic preconditioning in dogs. Anesthesiology 1999; 91: 1437-46.
51. Toller WG, Gross ER, Kersten JR, Pagel PS, Gross GJ, Warltier DC. Sarcolemmal and mitochondrial adenosine triphosphate-dependent potassium channels. Mechanism of desflurane-induced cardioprotection. Anesthesiology 2000; 92: 1731-9.
52. Kissin I, Stanbridge R, Bishop SP, Reves JG. Effect of halothane on myocardial infarct size in rats. Can Anaesth Soc J 1981; 28: 239-43.
53. Davis RF, Sidi A. Effect of isoflurane on the extent of myocardial necrosis and on systemic hemodynamics, regional myocardial blood flow, and regional myocardial metabolism in dogs after coronary artery occlusion. Anesth Analg 1989; 69: 575-86.
54. Davis RF, DeBoer LWV, Rude RE, Lowenstein E, Maroko PR. The effect of halothane anesthesia on myocardial necrosis, hemodynamic performance, and regional myocardial blood flow in dogs following coronary artery occlusion. Anesthesiology 1983; 59: 402-11.
55. Schlack W Hollmann M, Stunneck J, Thamer V. Effect of halothane on myocardial reoxygenation injury in the isolated rat heart. Br J Anaesth 1996; 76: 860-7.
56. 1) receptor in isolated rat heart. Br J Anaesth 2001; 87: 258-65.
57. Mohert J, Zahler S, Becker BF, Conzen PF. Inhibition of neutrophil activation by volatile anesthetics decreases adhesion to cultured human endothelial cells. Anesthesiology 1999; 90: 1372-81.
58. ATP channels in vivo. Anesthesiology 1999; 90: 246-56.
59. Mayfield KP, D'Alecy LG. Role of endogenous opioid peptides in the acute adaptation to hypoxia. Brain Res 1992; 582: 226-31.
60. Mayfield KP, D'Alecy LG. Delta-1 opioid agonist acutely increases hypoxic tolerance. J Pharmacol Exp Ther 1994; 268: 683-8.
61. 5-]-enkephalin) Letter. J Thorac Cardiovasc Surg 1994; 107: 964-7.
62. Miki T, Cohen MV, Downey JM. Opioid receptor contributes to ischemic preconditioning through protein kinase C activation in rabbits. Mol Cell Biochem 1998; 186: 3-12.
63. Liang BT, Gross GJ. Direct preconditioning of cardiac myocytes via opioid receptors and KT, channels. Circ Res 1999; 84: 1396-400.
64. Takasaki Y, Wolff RA, Chien GL, Van Winkle DM. Met5-enkephalin protects isolated adult rabbit cardiomyocytes via δ-opioid receptors. Am J Physiol 1999; 277: H2442-50.
65. Benedict PE, Benedict MB, Su TP, Bolling SE. Opiate drugs and δ-receptor-mediated myocardial protection. Circulation 1999; 100(Suppl II): II-357-60.
66. ATP channel linked mechanisms in rats. Br J Anaesth 2000; 84: 204-14.
67. Kato R, Foex P Fentanyl reduces infarction but not stunning via δ-opioid receptors and protein kinase C in rats. Br J Anaesth 2000; 84: 608-14.
68. Schwartz CF, Georges AJ, Gallagher MA, Yu L, Kilgore KS, Bolling SF Delta opioid receptors and low temperature myocardial protection. Ann Thorac Surg 1999; 68: 2089-92.
69. Bolling SF, Su TP, Childs KF, et al. The use of hibernation induction triggers for cardiac transplant preservation. Transplantation 1997; 63: 326-9.
70. Kevelaitis E, Peynet J, Mouas C, Launay JM, Menasche P. Opening of potassium channels. The common cardioprotective link between preconditioning and natural hibernation? Circulation 1999; 99: 3079-85.
71. Tsuchida A, Miura T, Tanno M, Nozawa Y, Kita H, Shimamoto K. Time window for the contribution of the δ-opioid receptor to cardioprotection by ischemic preconditioning in the rat heart. Cardiovasc Drugs Ther 1998; 12: 365-73.
72. Schultz JEJ, Hsu AK, Gross GJ. Ischemic preconditioning is mediated by a peripheral opioid receptor mechanism in the intact rat heart. J Mol Cell Cardiol 1997; 29: 1355-62.
73. Chien GL, Mohtadi K, Wolff RA, Van Winkle DM. Naloxone blockade of myocardial ischemic preconditioning does not require central nervous system participation. Basic Res Cardiol 1999; 94: 136-43.
74. Schultz JEJ, Gross GJ. Opioids and cardioprotection. Pharmacol Ther 2001; 89: 123-37.
75. Aitchison KA, Baxter GF, Awan MM, Smith RM, Yellon DM, Opie LH. Opposing effects on infarction of delta and kappa opioid receptor activation in the isolated rat heart: implications for ischemic preconditioning. Bas Res Cardiol 2000; 95: 1-10; discussion 1.
76. Bell SP, Sack MN, Patel A, Opie LH, Yellon DM. Delta opioid receptor stimulation mimics ischemic preconditioning in human heart muscle. J Am Coll Cardiol 2000; 36: 2296-302.
77. Tomai F, Crea F, Gaspardone A, et al. Effects of naloxone on myocardial ischemic preconditioning in humans. J Am Coll Cardiol 1999; 33: 1863-9.
78. Schultz JEJ, Hsu AK, Gross GJ. Ischemic preconditioning and morphine-induced cardioprotection involve the delta (δ)-opioid receptor in the intact rat heart. J Mol Cell Cardiol 1997; 29: 2187-95.
79. 1- but not μ- or κ-opioid receptors. Circulation 1998; 97: 1282-9.
80. Jaffe JH, Martin WX. Opioid analgesics and antagonists. In: Goodman Gilman A, Rall TW, Nies AS, Taylor P (Eds.). The Pharmacological Basis of Therapeutics, 8th ed. New York: Pergamon Press, 1990: 485-521.
81. ATP channels. Am J Physiol 1998; 274: H909-14.
82. ATP channels. Circ Res 1999; 84: 846-51.
83. McPherson BC, Yao Z. Signal transduction of opioid-induced cardioprotection in ischemia-reperfusion. Anesthesiology 2001; 94: 1082-8.
84. Bolling SF, Tramontini NL, Kilgore KS, Su TP, Oeltgen PR, Harlow HH. Use of "natural" hibernation induction triggers for myocardial protection. Ann Thorac Surg 1997; 64: 623-7.
85. ATP channels. Am J Physiol 2001; 280: H377-83.
86. Wang GY, Wu S, Pei JM, Yu XC, Wong TM. κ- but not δ-opioid receptors mediate effects of ischemic preconditioning on both infarct and arrhythmia in rats. Am J Physiol 2001; 280: H384-91.
87. Fryer RM, Pratt PF, Hsu AK, Gross GJ. Differential activation of extracellular signal regulated kinase isoforms in preconditioning and opioid-induced cardio-protection. J Pharmacol Exp Ther 2001; 296: 642-9.
88. Wu S, Li HY, Wong TM. Cardioprotection of preconditioning by metabolic inhibition in the rat ventricular myocyte. Involvement of κ-opioid receptor. Circ Res 1999; 84: 1388-95.
89. Zhou JJ, Pei JM, Wang GY, et al. Inducible HSP70 mediates delayed cardioprotection via U-50488H pretreatment in rat ventricular myocytes. Am J Physiol 2001; 281: H40-7.
90. Wang TL, Chang H, Hung CR, Tseng YZ. Attenuation of neutrophil and endothelial activation by intravenous morphine in patients with acute myocardial infarction. Am J Cardiol 1997; 80: 1532-5.
91. Wang TL, Chang H, Hung CR, Tseng YZ. Morphine preconditioning attenuates neutrophil activation in rat models of myocardial infarction. Cardiovasc Res 1998; 40: 557-63.
92. Hofbauer R, Frass M, Gmeiner B, et al. Effects of remifentanil on neutrophil adhesion, transmigration, and intercellular adhesion molecule expression. Acta Anaesthesiol Scand 2000; 44: 1232-7.
93. Szekely A, Heindl B, Zahler S, Conzen PF, Becker BF. Nonuniform behavior of intravenous anesthetics on postischemic adhesion of neutrophils in the guinea pig heart. Anesth Analg 2000; 90: 1293-300.
94. 2+ transients but not contraction in intact beating guinea pig hearts. Anesth Analg 2000; 90: 1286-92.
95. Buljubasic N, Marijic J, Berczi V, Supan DF, Kampine JP, Bosnjak ZJ. Differential effects of etomidate, propofol, and midazolam on calcium and potassium channel currents in canine myocardial cells. Anesthesiology 1996; 85: 1092-9.
96. Skoutelis A, Lianou P, Papageorgiou E, Kokkinis K, Alexopoulos K, Bassaris H. Effects of propofol and thiopentone on polymorphonuclear leukocyte functions in vitro. Acta Anaesthesiol Scand 1994; 38: 858-62.
97. Galley HF, Dubbels AM, Webster NR. The effect of midazolam and propofol on interleukin-8 from human polymorphonuclear leukocytes. Anesth Analg 1998; 86: 1289-93.
98. Mullenheim J, Frassdorf J, Preckel B, Thamer V, Schlack W. Ketamine, but not S(+)-ketamine, blocks ischemic preconditioning in rabbit hearts in vivo. Anesthesiology 2001; 94: 630-6.
99. 2+ concentration in neonatal rat cardiomyocytes. Anesth Analg 1999; 89: 1417-22.
100. Ko SH, Lee SK, Han YJ, et al. Blockade of myocardial ATP-sensitive potassium channels by ketamine. Anesthesiology 1997; 87: 68-74.
101. Tsutsumi Y, Oshita S, Kitahata H, Kuroda Y, Kawano T, Nakaya Y. Blockade of adenosine triphosphate-sensitive potassium channels by thiamylal in rat ventricular myocytes. Anesthesiology 2000; 92: 1154-9.
102. Conradie S, Coetzee A, Coetzee J. Anesthetic modulation of myocardial ischemia and reperfusion injury in pigs: comparison between halothane and sevoflurane. Can J Anesth 1999; 46: 71-81.
103. Haessler R, Kuzume K, Chien GL, Wolff RA, Davis RF, Van Winkle DM. Anaesthetics alter the magnitude of infarct limitation by ischaemic preconditioning. Cardiovasc Res 1994; 28: 1574-80.
104. Tamaki F, Oguchi T, Kashimoto S, Nonaka A, Kumazawa T. Effects of propofol on ischemia and reperfusion in the isolated rat heart compared with thiamylal. Jpn Heart J 2001; 42: 193-206.
105. Ross S, Munoz H, Piriou V, Ryder WA, Foex P. A comparison of the effects of fentanyl and propofol on left ventricular contractility during myocardial stunning. Acta Anaesthesiol Scand 1998; 42: 23-31.
106. Meissner A, Weber TP, Van Aken H, Zbieranek K, Rolf N. Recovery from myocardial stunning is faster with desflurane compared with propofol in chronically instrumented dogs. Anesth Analg 2000; 91: 1333-8.
107. Belhomme D, Peynet J, Louzy M, Launay JM, Kitakaze M, Menasche P. Evidence for preconditioning by isoflurane in coronary artery bypass graft surgery. Circulation 1999; 100(Suppl II): II-340-4.
108. Tomai F, De Paulis R, Penta de Peppo A, et al. Beneficial impact of isoflurane during coronary bypass surgery on troponin I release. G Ital Cardiol 1999; 29: 1007-14.
109. Penta de Peppo A, Polisca P, Tomai F, et al. Recovery of LV contractility in man is enhanced by preischemic administration of enflurane. Ann Thorac Surg 1999; 68: 112-8.
110. Chauvin M, Sandouk, P, Scherrmann JM, Farinotti R, Strumza P, Duvaldestin P. Morphine pharmacokinetics in renal failure. Anesthesiology of analgesic efficacy of oxycodone and morphine in postoperative intravenous patient-controlled analgesia. Acta Anaesthesiol Scand 1998; 42: 576-80.
111. Silvast M, Rosenberg P, Seppala T, Svartling N, Pitkanen M. Comparison of analgesic efficacy of oxycodone and morphine in postoperative intravenous patient-controlled analgesia. Anesthesiology 1987; 66: 327-31.
112. Hull CJ. Pharmacokinetics and pharamacodynamics. In: Prys-Roberts C, Brown BRJ (Eds.). International Practice of Anaesthesia. Oxford: Butterworth-Heinemann, 1996: 1/13/1-1/17.
113. Sprigge JS, Wynands JE, Whalley DG, et al. Fentanyl infusion anesthesia for aortocoronary bypass surgery: plasma levels and hemodynamic response. Anesth Analg 1982; 61: 972-8.
114. Shafer A, Doze VA, Shafer SL, White PF. Pharmacokinetics and pharmacodynamics of propofol infusions during general anesthesia. Anesthesiology 1988; 69: 348-56.
115. Ebel D, Schlack W Comfere T, Preckel B, Thamer V. Effect of propofol on reperfusion injury after regional ischaemia in the isolated rat heart. Br J Anaesth 1999; 83: 903-8.
116. Szekely A, Heindl B, Zahler S, Conzen PF, Becker BF. S(+)-ketamine, but not R(-)-ketamine, reduces postischemic adherence of neutrophils in the coronary system of isolated guinea pig hearts. Anesth Analg 1999; 88: 1017-24.
117. Idvall J, Ahlgren I, Aronsen KF, Stenberg P. Ketamine infusions: pharmacokinetics and clinical effects. Br J Anaesth 1979; 51: 1167-73.
118. Li F, Hayes JK, Wong KC, Szakacs J. Administration of sevoflurane and isoflurane prior to prolonged global ischemia improves heart function in isolated rat heart. Acta Anaesthesiol Sinica 2000; 38: 113-21.
119. Komai H, Berkoff HA, Rusy BF. Protection of ischemic rat heart by cardioplegic doses of pentobarbital. J Surg Res 1981; 30: 42-6.
120. Ruigrok TJC, Slade AM, van der Meer P, et al. Different effects of thiopental in severe hypoxia, total ischemia, and low-flow ischemia in rat heart muscle. Anesthesiology 1985; 63: 172-8.
121. stunned" myocardium following variable periods of ischemia in conscious and anesthetized dogs. Am Heart J 1987; 114: 696-703.
122. Sinclair DM, de Moes D, Boink AB, Ruigrok TJ. A protective effect of thiopentone on hypoxic heart muscle. J Mol Cell Cardiol 1980; 12: 225-7.
123. 2+ transients and contraction in rat ventricular myocytes. Anesthesiology 1998; 89: 1532-42.
124. Ela C, Barg J, Vogel Z, Hasin Y, Eilam Y. Distinct components of morphine effects on cardiac myocytes are mediated by the κ and δ opioid receptors. J Mol Cell Cardiol 1997; 29: 711-20.
125. Kanesaki T, Saeki M, Ooi Y, et al. Morphine prevents peroxynitrite -induced death of human neuroblastoma SH-SY5Y cells through a direct scavenging action. Eur J Pharmacol 1999; 372: 319-24.
126. Kang MY, Tsuchiya M, Packer L, Manabe M. In vitro study on antioxidant potential of various drugs used in the perioperative period. Acta Anaesthesiol Scand 1998; 42: 4-12.
127. Weigand MA, Schmidt H Zhao Q, Plaschke K, Martin E, Bardenbeuer HJ. Ketamine modulates the stimulated adhesion molecule expression on human neutrophils in vitro. Anesth Analg 2000; 90: 206-12.
128. 2+ transients and contraction in rat ventricular myocytes at supraclinical concentrations. Anesthesiology 1998; 88: 781-91.
129. Kunst G, Martin E, Graf BM, Hagl S, Vahl CF. Actions of ketamine and its isomers on contractility and calcium transients in human myocardium. Anesthesiology 1999; 90: 1363-71.
130. Nishina K, Akamatsu H, Mikawa K, et al. The inhibitory effects of thiopental, midazolam, and ketamine on human neutrophil functions. Anesth Analg 1998; 86: 159-65.
131. Sakai F, Hiraoka M, Amaha K. Comparative actions of propofol and thiopentone on cell membranes of isolated guineapig ventricular myocytes. Br J Anaesth 1996; 77: 508-16.
132. Martynyuk AE, Morey TE, Raatikainen MJP, Seubert CN, Dennis DM. Ionic mechanisms mediating the differential effects of methohexital and thiopental on action potential duration in guinea pig and rabbit isolated ventricular myocytes. Anesthesiology 1999; 90: 156-64.
133. Almaas R, Sangstad OD, Pleasure D, Rootwelt T. Effect of barbiturates on hydroxyl radicals, lipid peroxidation, and hypoxic cell death in human NT2-N neurons. Anesthesiology 2000; 92: 764-74.
134. Nonaka A, Kashimoto S, Imamura M, Furuya A, Kumazawa T. Mechanism of the negative inotropic effect of midazolam and diazepam in cultured foetal mouse cardiac myocytes. Eur J Anaesthesiol 1997; 14: 481-7.